Stock listing
3696 Stock Price, News, Filings & Events — Insilico Medicine Cayman Topco
Selected listing: 3696 · HKEX · HKD · HK
This page tracks Insilico Medicine Cayman Topco's 3696:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 3696:HKEX. 3696:HKEX is the stock-level entry point for investors researching Insilico Medicine Cayman Topco, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Insilico Medicine Cayman Topco, trading under the ticker 3696 on the Hong Kong market, has a market capitalization of approximately 3.58 billion. The company focuses on advancing artificial intelligence-driven drug discovery and development. Its innovative approach aims to enhance the efficiency and effectiveness of pharmaceutical research.

- Ticker
- 3696:HKEX
- Asset type
- Stock
- Market cap
- $3.44B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD
Insilico Medicine Cayman Topco 3696:HKEX stock context
This page tracks Insilico Medicine Cayman Topco's 3696:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 3696:HKEX. 3696:HKEX is the stock-level entry point for investors researching Insilico Medicine Cayman Topco, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Insilico Medicine Cayman Topco, trading under the ticker 3696 on the Hong Kong market, has a market capitalization of approximately 3.58 billion. The company focuses on advancing artificial intelligence-driven drug discovery and development. Its innovative approach aims to enhance the efficiency and effectiveness of pharmaceutical research.
Research Insilico Medicine Cayman Topco
Insilico Medicine Cayman Topco investor report
Review AI stock analysis and investor report context for 3696:HKEX.
Insilico Medicine Cayman Topco company profile
View the public company page for Insilico Medicine Cayman Topco on 6ix.
Insilico Medicine Cayman Topco news
Read company news and market updates connected to Insilico Medicine Cayman Topco.
Insilico Medicine Cayman Topco investor events
Find investor webinars, events, and replay context for Insilico Medicine Cayman Topco.
Alternate listings
ISLMF:OTC
US · USD
Alternate listing for Insilico Medicine Cayman Topco; the primary context on this page is 3696:HKEX.
A41XT7:LS
DE · EUR
Alternate listing for Insilico Medicine Cayman Topco; the primary context on this page is 3696:HKEX.
O15:TRADEGATE
DE · EUR
Alternate listing for Insilico Medicine Cayman Topco; the primary context on this page is 3696:HKEX.
O15:FWB
DE · EUR
Alternate listing for Insilico Medicine Cayman Topco; the primary context on this page is 3696:HKEX.
O15:DUS
DE · EUR
Alternate listing for Insilico Medicine Cayman Topco; the primary context on this page is 3696:HKEX.